Loading…

Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya

The coronavirus disease 2019 (COVID-19), first reported in Kenya on March 13, 2020, is spreading rapidly. As of 30th June 2020, over 6,190 cases had been reported with a case fatality of 3.2%. Previous Coronavirus outbreaks have been associated with a significant burden of Cardiovascular disease. Fo...

Full description

Saved in:
Bibliographic Details
Published in:The Pan African medical journal 2020, Vol.35 (Suppl 2), p.120-120
Main Authors: Ogeng'o, Julius, Karau, Paul Bundi, Misiani, Musa, Cheruiyot, Isaac, Olabu, Beda, Kariuki, Brian Ngure
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 120
container_issue Suppl 2
container_start_page 120
container_title The Pan African medical journal
container_volume 35
creator Ogeng'o, Julius
Karau, Paul Bundi
Misiani, Musa
Cheruiyot, Isaac
Olabu, Beda
Kariuki, Brian Ngure
description The coronavirus disease 2019 (COVID-19), first reported in Kenya on March 13, 2020, is spreading rapidly. As of 30th June 2020, over 6,190 cases had been reported with a case fatality of 3.2%. Previous Coronavirus outbreaks have been associated with a significant burden of Cardiovascular disease. For COVID-19, however, there has been no direct reference to potential long-term cardiovascular effects, especially in Africa where atherosclerotic diseases are an emerging challenge. This article, therefore, aims at describing possible long-term effects on the burden of atherosclerotic disease among Kenyans. Available data indicate that COVID-19 and cardiovascular disease share pathomechanisms and risk factors which include ACE2 receptor invasion and renin-angiotensin system signaling, oxidative stress, systemic inflammation, and endothelial dysfunction. Further, SAR-COV-2 infection causes dyslipidemia, dysglycemia, kidney, and liver disease. These mechanisms and diseases constitute risk factors for the initiation, progression, and complications of atherosclerosis. In Kenya, the common risk factors for atherosclerotic cardiovascular disease, and COVID-19 comprising Hypertension, Diabetes Mellitus, Obesity, Cigarette Smoking, Respiratory Tract Infections, Pulmonary Thromboembolism, Chronic Obstructive Pulmonary Disease, and Renal disease are not uncommon and continue to increase. In essence, the prevalence of the common risk factors/comorbidities, between COVID-19 and CVD occurrence of ACE2 receptors on the endothelium, and hence pathomechanisms of SARS-COV-2 infection imply that COVID-19 may increase the burden of atherosclerotic disease in Kenya. All due care should be taken, to prevent and effectively manage the disease, to avert an imminent epidemic of atherosclerotic disease.
doi_str_mv 10.11604/pamj.supp.2020.35.24762
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2467846025</sourcerecordid><originalsourceid>FETCH-LOGICAL-p158t-fcdf62288c33f92f03d3d7947c19909865fb71de4b348e71a3c9e4a890a4b73d3</originalsourceid><addsrcrecordid>eNpVzDtPwzAABGALCdFS-A8ey5DgV_xYkFDKo6JSF2CNHMehrhI72Eml_nsq6MJyN9zpAwBilGPMEbsfdL_P0zQMOUEE5bTICROcXIA5VlRkkks5A9cp7RHiXFJ0BWaUEkmQKOagL0MMXh9cnBJcuWR1spAgrOCy3H6uVxlWdzDZEY4BOm_i715PsbEehhbqcWdjSKY75egMNDo2Lhx0MlOnI2zOoPPwzfqjvgGXre6SvT33Anw8P72Xr9lm-7IuHzfZgAs5Zq1pWk6IlIbSVpEW0YY2QjFhsFJISV60tcCNZTVl0gqsqVGWaamQZrU4nRfg4c8dprq3jbF-jLqrhuh6HY9V0K76v3i3q77CoRJcigIVJ2B5BmL4nmwaq94lY7tOexumVBHGhWQckYL-ALGjdoc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2467846025</pqid></control><display><type>article</type><title>Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Ogeng'o, Julius ; Karau, Paul Bundi ; Misiani, Musa ; Cheruiyot, Isaac ; Olabu, Beda ; Kariuki, Brian Ngure</creator><creatorcontrib>Ogeng'o, Julius ; Karau, Paul Bundi ; Misiani, Musa ; Cheruiyot, Isaac ; Olabu, Beda ; Kariuki, Brian Ngure</creatorcontrib><description>The coronavirus disease 2019 (COVID-19), first reported in Kenya on March 13, 2020, is spreading rapidly. As of 30th June 2020, over 6,190 cases had been reported with a case fatality of 3.2%. Previous Coronavirus outbreaks have been associated with a significant burden of Cardiovascular disease. For COVID-19, however, there has been no direct reference to potential long-term cardiovascular effects, especially in Africa where atherosclerotic diseases are an emerging challenge. This article, therefore, aims at describing possible long-term effects on the burden of atherosclerotic disease among Kenyans. Available data indicate that COVID-19 and cardiovascular disease share pathomechanisms and risk factors which include ACE2 receptor invasion and renin-angiotensin system signaling, oxidative stress, systemic inflammation, and endothelial dysfunction. Further, SAR-COV-2 infection causes dyslipidemia, dysglycemia, kidney, and liver disease. These mechanisms and diseases constitute risk factors for the initiation, progression, and complications of atherosclerosis. In Kenya, the common risk factors for atherosclerotic cardiovascular disease, and COVID-19 comprising Hypertension, Diabetes Mellitus, Obesity, Cigarette Smoking, Respiratory Tract Infections, Pulmonary Thromboembolism, Chronic Obstructive Pulmonary Disease, and Renal disease are not uncommon and continue to increase. In essence, the prevalence of the common risk factors/comorbidities, between COVID-19 and CVD occurrence of ACE2 receptors on the endothelium, and hence pathomechanisms of SARS-COV-2 infection imply that COVID-19 may increase the burden of atherosclerotic disease in Kenya. All due care should be taken, to prevent and effectively manage the disease, to avert an imminent epidemic of atherosclerotic disease.</description><identifier>EISSN: 1937-8688</identifier><identifier>DOI: 10.11604/pamj.supp.2020.35.24762</identifier><identifier>PMID: 33282075</identifier><language>eng</language><publisher>The African Field Epidemiology Network</publisher><ispartof>The Pan African medical journal, 2020, Vol.35 (Suppl 2), p.120-120</ispartof><rights>Julius Ogeng’o et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687505/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687505/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,37013,53791,53793</link.rule.ids></links><search><creatorcontrib>Ogeng'o, Julius</creatorcontrib><creatorcontrib>Karau, Paul Bundi</creatorcontrib><creatorcontrib>Misiani, Musa</creatorcontrib><creatorcontrib>Cheruiyot, Isaac</creatorcontrib><creatorcontrib>Olabu, Beda</creatorcontrib><creatorcontrib>Kariuki, Brian Ngure</creatorcontrib><title>Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya</title><title>The Pan African medical journal</title><description>The coronavirus disease 2019 (COVID-19), first reported in Kenya on March 13, 2020, is spreading rapidly. As of 30th June 2020, over 6,190 cases had been reported with a case fatality of 3.2%. Previous Coronavirus outbreaks have been associated with a significant burden of Cardiovascular disease. For COVID-19, however, there has been no direct reference to potential long-term cardiovascular effects, especially in Africa where atherosclerotic diseases are an emerging challenge. This article, therefore, aims at describing possible long-term effects on the burden of atherosclerotic disease among Kenyans. Available data indicate that COVID-19 and cardiovascular disease share pathomechanisms and risk factors which include ACE2 receptor invasion and renin-angiotensin system signaling, oxidative stress, systemic inflammation, and endothelial dysfunction. Further, SAR-COV-2 infection causes dyslipidemia, dysglycemia, kidney, and liver disease. These mechanisms and diseases constitute risk factors for the initiation, progression, and complications of atherosclerosis. In Kenya, the common risk factors for atherosclerotic cardiovascular disease, and COVID-19 comprising Hypertension, Diabetes Mellitus, Obesity, Cigarette Smoking, Respiratory Tract Infections, Pulmonary Thromboembolism, Chronic Obstructive Pulmonary Disease, and Renal disease are not uncommon and continue to increase. In essence, the prevalence of the common risk factors/comorbidities, between COVID-19 and CVD occurrence of ACE2 receptors on the endothelium, and hence pathomechanisms of SARS-COV-2 infection imply that COVID-19 may increase the burden of atherosclerotic disease in Kenya. All due care should be taken, to prevent and effectively manage the disease, to avert an imminent epidemic of atherosclerotic disease.</description><issn>1937-8688</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVzDtPwzAABGALCdFS-A8ey5DgV_xYkFDKo6JSF2CNHMehrhI72Eml_nsq6MJyN9zpAwBilGPMEbsfdL_P0zQMOUEE5bTICROcXIA5VlRkkks5A9cp7RHiXFJ0BWaUEkmQKOagL0MMXh9cnBJcuWR1spAgrOCy3H6uVxlWdzDZEY4BOm_i715PsbEehhbqcWdjSKY75egMNDo2Lhx0MlOnI2zOoPPwzfqjvgGXre6SvT33Anw8P72Xr9lm-7IuHzfZgAs5Zq1pWk6IlIbSVpEW0YY2QjFhsFJISV60tcCNZTVl0gqsqVGWaamQZrU4nRfg4c8dprq3jbF-jLqrhuh6HY9V0K76v3i3q77CoRJcigIVJ2B5BmL4nmwaq94lY7tOexumVBHGhWQckYL-ALGjdoc</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Ogeng'o, Julius</creator><creator>Karau, Paul Bundi</creator><creator>Misiani, Musa</creator><creator>Cheruiyot, Isaac</creator><creator>Olabu, Beda</creator><creator>Kariuki, Brian Ngure</creator><general>The African Field Epidemiology Network</general><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2020</creationdate><title>Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya</title><author>Ogeng'o, Julius ; Karau, Paul Bundi ; Misiani, Musa ; Cheruiyot, Isaac ; Olabu, Beda ; Kariuki, Brian Ngure</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p158t-fcdf62288c33f92f03d3d7947c19909865fb71de4b348e71a3c9e4a890a4b73d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ogeng'o, Julius</creatorcontrib><creatorcontrib>Karau, Paul Bundi</creatorcontrib><creatorcontrib>Misiani, Musa</creatorcontrib><creatorcontrib>Cheruiyot, Isaac</creatorcontrib><creatorcontrib>Olabu, Beda</creatorcontrib><creatorcontrib>Kariuki, Brian Ngure</creatorcontrib><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Pan African medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ogeng'o, Julius</au><au>Karau, Paul Bundi</au><au>Misiani, Musa</au><au>Cheruiyot, Isaac</au><au>Olabu, Beda</au><au>Kariuki, Brian Ngure</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya</atitle><jtitle>The Pan African medical journal</jtitle><date>2020</date><risdate>2020</risdate><volume>35</volume><issue>Suppl 2</issue><spage>120</spage><epage>120</epage><pages>120-120</pages><eissn>1937-8688</eissn><abstract>The coronavirus disease 2019 (COVID-19), first reported in Kenya on March 13, 2020, is spreading rapidly. As of 30th June 2020, over 6,190 cases had been reported with a case fatality of 3.2%. Previous Coronavirus outbreaks have been associated with a significant burden of Cardiovascular disease. For COVID-19, however, there has been no direct reference to potential long-term cardiovascular effects, especially in Africa where atherosclerotic diseases are an emerging challenge. This article, therefore, aims at describing possible long-term effects on the burden of atherosclerotic disease among Kenyans. Available data indicate that COVID-19 and cardiovascular disease share pathomechanisms and risk factors which include ACE2 receptor invasion and renin-angiotensin system signaling, oxidative stress, systemic inflammation, and endothelial dysfunction. Further, SAR-COV-2 infection causes dyslipidemia, dysglycemia, kidney, and liver disease. These mechanisms and diseases constitute risk factors for the initiation, progression, and complications of atherosclerosis. In Kenya, the common risk factors for atherosclerotic cardiovascular disease, and COVID-19 comprising Hypertension, Diabetes Mellitus, Obesity, Cigarette Smoking, Respiratory Tract Infections, Pulmonary Thromboembolism, Chronic Obstructive Pulmonary Disease, and Renal disease are not uncommon and continue to increase. In essence, the prevalence of the common risk factors/comorbidities, between COVID-19 and CVD occurrence of ACE2 receptors on the endothelium, and hence pathomechanisms of SARS-COV-2 infection imply that COVID-19 may increase the burden of atherosclerotic disease in Kenya. All due care should be taken, to prevent and effectively manage the disease, to avert an imminent epidemic of atherosclerotic disease.</abstract><pub>The African Field Epidemiology Network</pub><pmid>33282075</pmid><doi>10.11604/pamj.supp.2020.35.24762</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1937-8688
ispartof The Pan African medical journal, 2020, Vol.35 (Suppl 2), p.120-120
issn 1937-8688
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7687505
source Publicly Available Content Database; PubMed Central
title Coronavirus Disease 2019 (COVID-19) set to increase burden of atherosclerotic cardiovascular disease in Kenya
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T09%3A11%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coronavirus%20Disease%202019%20(COVID-19)%20set%20to%20increase%20burden%20of%20atherosclerotic%20cardiovascular%20disease%20in%20Kenya&rft.jtitle=The%20Pan%20African%20medical%20journal&rft.au=Ogeng'o,%20Julius&rft.date=2020&rft.volume=35&rft.issue=Suppl%202&rft.spage=120&rft.epage=120&rft.pages=120-120&rft.eissn=1937-8688&rft_id=info:doi/10.11604/pamj.supp.2020.35.24762&rft_dat=%3Cproquest_pubme%3E2467846025%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p158t-fcdf62288c33f92f03d3d7947c19909865fb71de4b348e71a3c9e4a890a4b73d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2467846025&rft_id=info:pmid/33282075&rfr_iscdi=true